Authors: Vallera, DA

Citation: Da. Vallera, Gene therapy with immunotoxins, METH MOL B, 166, 2001, pp. 235-246

Authors: Vallera, DA Jin, N Baldrica, JMR Panoskaltsis-Mortari, A Chen, SY Blazar, BR

Citation: Da. Vallera et al., Retroviral immunotoxin gene therapy of acute myelogenous leukemia in mice using cytotoxic T cells transduced with an interleukin 4/diphtheria toxin gene, CANCER RES, 60(4), 2000, pp. 976-984

Authors: Vallera, DA Kuroki, DW Panoskaltsis-Mortari, A Buchsbaum, DJ Rogers, BE Blazar, BR

Citation: Da. Vallera et al., Molecular modification of a recombinant anti-CD3 epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model, BLOOD, 96(3), 2000, pp. 1157-1165

Authors: Vallera, DA Seo, SY Panoskaltsis-Mortari, A Griffin, JD Blazar, BR

Citation: Da. Vallera et al., Targeting myeloid leukemia with a DT390-mIL-3 fusion immunotoxin: ex vivo and in vivo studies in mice, PROTEIN ENG, 12(9), 1999, pp. 779-785

Authors: Blazar, BR Taylor, PA Panoskaltsis-Mortari, A Sharpe, AH Vallera, DA

Citation: Br. Blazar et al., Opposing roles of CD28 : B7 and CTLA-4 : B7 pathways in regulating in vivoalloresponses in murine recipients of MHC disparate T cells, J IMMUNOL, 162(11), 1999, pp. 6368-6377

Authors: Herrlinger, U Schmidberger, H Buchholz, R Wehrmann, M Vallera, DA Schabet, M

Citation: U. Herrlinger et al., Intrathecal therapy of leptomeningeal CEM T-cell lymphoma in nude rats with anti-CD7 ricin toxin A chain immunotoxin, J NEURO-ONC, 40(1), 1998, pp. 1-9